Tonix Pharmaceuticals Investor Presentation 2022

Tonix Pharmaceuticals Holding Corp. presents its corporate strategy and pipeline of innovative therapeutic candidates across multiple disease areas. The presentation outlines the company's integrated development approach to advance programs into clinical trials while focusing on unmet medical needs and maximizing asset potential.